Find similar content

Source channel @githubtrending · Post #14989 · Jul 23

#c_lang#bluetooth#bluetooth_le#embedded#embedded_c#iot#mcu#microcontroller#real_time#rtos#zephyr#zephyr_rtos#zephyros Zephyr is a free, open-source real-time operating system (RTOS) designed for small, resource-limited devices like sensors, wearables, and IoT gateways. It supports many hardware types such as ARM, Intel x86, and RISC-V, making it flexible for different projects. Zephyr is modular, so you can include only what you need, saving memory and power. It focuses on security with features like memory protection and secure boot. It also offers built-in networking and tools for easy development and testing. This helps you build reliable, fast, and secure embedded systems efficiently, especially for IoT and real-time applications[1][2][3]. https://github.com/zephyrproject-rtos/zephyr

Hashtags

#c_lang #bluetooth #bluetooth_le #embedded #embedded_c #iot #mcu #microcontroller #real_time #rtos #zephyr #zephyr_rtos #zephyros

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment